Nuclear Binding Protein Drives Trisomy 21 Cardiac Defects
- New research identifies a key protein contributing to heart defects in individuals with Down syndrome, offering potential targets for future therapies.
- Down syndrome (DS), caused by a full or partial extra copy of chromosome 21, is frequently associated with congenital heart defects (CHDs). Approximately half of the roughly 6,000...
- while the correlation between trisomy 21 and CHDs has been known for decades, the precise mechanisms remained elusive.Researchers have long sought to pinpoint which genes on the extra...
“`html
Unraveling the Genetic Link Between Down Syndrome and Congenital Heart Defects
Table of Contents
New research identifies a key protein contributing to heart defects in individuals with Down syndrome, offering potential targets for future therapies.
The Connection: Down syndrome and Heart Disease
Down syndrome (DS), caused by a full or partial extra copy of chromosome 21, is frequently associated with congenital heart defects (CHDs). Approximately half of the roughly 6,000 babies born with Down syndrome annually in the United States-around 2,600 infants-also present with CHDs. This represents a significantly elevated risk; roughly 1% (40,000) of all births in the U.S.involve a CHD.
while the correlation between trisomy 21 and CHDs has been known for decades, the precise mechanisms remained elusive.Researchers have long sought to pinpoint which genes on the extra chromosome 21 are responsible for the increased risk. Identifying these genes is critical for developing targeted therapies.
Identifying the Culprit: A Nuclear Binding Protein
A team led by Sanjeev S. Ranade, PhD, at Sanford Burnham Prebys, has identified a nuclear binding protein as a key contributor to trisomy 21-related CHDs. Published in the journal Nature, their research sheds light on the “why” behind the genetic link. The study focused on understanding how the excess genetic material from chromosome 21 disrupts normal heart development.
the researchers discovered that the increased dosage of certain genes on chromosome 21 leads to an overabundance of this nuclear binding protein. This, in turn, disrupts crucial developmental processes within the heart, specifically affecting the junctions between the atria-the heart’s upper chambers.
The Impact: Atrioventricular Canal Defects
Children with Down syndrome exhibit a 1,000-fold increase in atrioventricular canal (AVC) defects. These defects disrupt the normal flow of blood through the heart, leading to oxygen-poor blood circulating to the body. AVC defects are among the most common and severe CHDs associated with Down syndrome, frequently enough requiring early surgical intervention.
| Congenital Heart Defect | Prevalence in General Population | Prevalence in Down Syndrome Population |
|---|---|---|
| Atrioventricular Canal (AVC) Defect | ~5 per 10,000 live births | ~40-60% of Down Syndrome cases |
| Ventricular Septal Defect (VSD) | ~1 per 2,000 live births | ~30-40% of Down Syndrome cases |
| Tetralogy of Fallot | ~5 per 10,000 live births | ~5-10% of Down Syndrome cases |
The study’s findings suggest that the identified nuclear binding protein plays a critical role in the development of these AVC defects. By understanding this mechanism, researchers can begin to